title: Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus.
abstract: Patients with type 2 diabetes mellitus are at 2 to 4 times increased risk of cardiovascular events compared with those without diabetes, both among patients with multiple risk factors only and those with established atherothrombosis. In this review, we provide recommendations for the use of statins and aspirin for the prevention of cardiovascular events in high-risk patients with diabetes mellitus.
authors: TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
authors: Jacob A
authors: JA
authors: Udell
authors: Benjamin M
authors: BM
authors: Scirica
authors: Eugene
authors: E
authors: Braunwald
authors: Itamar
authors: I
authors: Raz
authors: Ph Gabriel
authors: PG
authors: Steg
authors: Jaime
authors: J
authors: Davidson
authors: Boaz
authors: B
authors: Hirshberg
authors: Deepak L
authors: DL
authors: Bhatt
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D001241:Aspirin